Chronic Heart Failure, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus
Conditions
Keywords
Telemedicine
Brief summary
The DREAMING clinical trial is part of the DREAMING project, which has the objective to demonstrate that the DREAMING platform consisting of integrated health monitoring, alarm handling and videoconferencing services produces clinical benefits to its users and economic benefits to the health authorities. The study evaluates the long-term (30 months) effect of continuous use of the DREAMING subsystems and is testing the hypothesis that such use is superior to usual care alone in reducing the deterioration of health related quality of life that is associated to age and chronic disease. It also tests the hypothesis that the DREAMING environment is superior to usual care in delaying the transfer to nursing or elderly homes and in reducing the incidence and duration of hospitalisation episodes. The trial will also evaluate the cost-effectiveness of the DREAMING platform. Outcomes are assessed in six different health care systems (Denmark, Estonia, Germany, Italy, Spain and Sweden) and will represent a basis for the adoption of DREAMING services by the respective health authorities.
Detailed description
Homes of participants are equipped with environmental sensors, motion detection, and with wireless sensors for blood pressure, blood glucose, body weight, blood oxygen saturation, peak expiratory flow and electrocardiogram. Disease related parameters are monitored at least daily and the measured values are transmitted to a central monitoring unit. In case of abnormal values, health alarms are generated and transmitted to the local health authorities to trigger eventual intervention by the physicians and nurses who normally follow the participants. Participants and health professionals can stay in contact via an easy to use, home television based videoconferencing system. Participants are also equipped with a a personal alarm and GPS-enhanced localisation system.
Interventions
DEVICEWireless monitors for disease specific clinical parameters.
Homes of participants will be equipped with wireless monitors for blood pressure, blood oxygen, blood glucose, peak expiratory flow, electrocardiogram, body weight. All vital parameters are monitored on a continuous, at least daily basis and obtained values are transmitted to a monitoring centre. Abnormal values are classified for their health risk and health alarms and/or intervention of health professionals is triggered.
Sponsors
Health Information Management, Belgium
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Inclusion criteria: * Diagnosis of chronic heart failure * Diagnosis of diabetes mellitus * Diagnosis of chronic obstructive pulmonary disease Only in the case that the number of recruited participants is not sufficient, inclusion criteria can be extended to one or more of the following conditions: * History of myocardial infarction * History of stroke (brain ischemia or hemorrhage) * History of falls within the last two years * Hospitalization during the last two years (for every reason)
Exclusion criteria
* Not willing to participate (e.g non signing informed consent) * Inability to use the DREAMING equipment * Significant impairment of language comprehension or expression (aphasia) * Diagnosis of dementia * Completely dependent on others for the activities of daily living * Living without access to ISDN or DSL service
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Health related quality of life as assessed by the SF-36 questionnaire, at the beginning, at midterm and at the end of the trial period | 0, 15, 30 months |
Secondary
| Measure | Time frame |
|---|---|
| Total and average length of stay in hospital | Measured at month 30 |
| Number of consultations with general practitioners | Measured at month 30 |
| Number of consultations with medical specialists | Measured at month 30 |
| Number of home visits by nurses | Measured at month 30 |
| Number of ambulance transports | Measured at month 30 |
| Number of accesses to emergency rooms | Measured at month 30 |
| Time to permanent transfer to elderly homes | Measured at month 30 |
| Number of femur fractures | Measured at month 30 |
| HbA1c change over time (only for participants with a diagnosis of diabetes) | Measured at month 30 |
| Survival | Measured at month 30 |
| Depression as measured by HADS | Measured at months 0, 15 and 30 |
| Number of hospitalisations | Measured at month 30 |
| Number of permanent transfers to elderly homes | Measured at month 30 |
| Number of falls | Measured at month 30 |
Countries
Denmark, Estonia, Germany, Italy, Spain, Sweden
Contacts
Primary ContactReinhard W Prior, M.D.
Outcome results
None listed